GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Enovix Corp (NAS:ENVX) » Definitions » Change In Receivables

Enovix (Enovix) Change In Receivables : $-0.37 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Enovix Change In Receivables?

Enovix's change in receivables for the quarter that ended in Dec. 2023 was $-0.54 Mil. It means Enovix's Accounts Receivable increased by $0.54 Mil from Sep. 2023 to Dec. 2023 .

Enovix's change in receivables for the fiscal year that ended in Dec. 2023 was $-0.37 Mil. It means Enovix's Accounts Receivable increased by $0.37 Mil from Dec. 2022 to Dec. 2023 .

Enovix's Accounts Receivable for the quarter that ended in Dec. 2023 was $0.91 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Enovix's Days Sales Outstanding for the three months ended in Dec. 2023 was 11.24.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Enovix's liquidation value for the three months ended in Dec. 2023 was $8.66 Mil.


Enovix Change In Receivables Historical Data

The historical data trend for Enovix's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enovix Change In Receivables Chart

Enovix Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Change In Receivables
- - -0.17 -0.37

Enovix Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.16 0.15 -0.02 0.04 -0.54

Enovix Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enovix  (NAS:ENVX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Enovix's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.909/7.381*91
=11.24

2. In Ben Graham's calculation of liquidation value, Enovix's accounts receivable are only considered to be worth 75% of book value:

Enovix's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=306.815-303.201+0.75 * 0.909+0.5 * 8.737
=8.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enovix Change In Receivables Related Terms

Thank you for viewing the detailed overview of Enovix's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Enovix (Enovix) Business Description

Traded in Other Exchanges
Address
3501 W. Warren Avenue, Fremont, CA, USA, 94538
Enovix Corp is engaged in the business of advanced silicon-anode lithium-ion battery development and production. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable the widespread utilization of renewable energy.
Executives
Rajendra K Talluri director, officer: President and CEO 3501 W. WARREN AVENUE, FREMONT CA 94538
Betsy S Atkins director
Arthi Chakravarthy officer: See Remarks C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Farhan Ahmad officer: Chief Financial Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Bernard Gutmann director ON SEMICONDUCTOR C/O V PECORA (M/D A700), 5005 EAST MCDOWELL ROAD, PHOENIX AZ 85008
Ralph H Schmitt officer: Chief Commercial Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Thurman J Rodgers director, 10 percent owner 535 EASTVIEW WAY, WOODSIDE CA 94062
Ashok Lahiri officer: Chief Technology Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Ajay Marathe officer: Chief Operating Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Harrold J Rust director, officer: President and CEO C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Gardner Cameron Dales officer: Chief Commercial Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Eclipse Fund Iii, L.p. 10 percent owner 514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
Eclipse Gp Iii, Llc 10 percent owner 514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
J Daniel Mccranie director C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Edward J Hejlek officer: See Remarks C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538